I ran into fellow blogger David Swanner of the South Carolina Trial Law Blog in Toronto. He was kind enough to grab me as I was walking along oblivious to my surroundings and introduce himself. He has a great blog and a great collection of powerpoint presentations from various lawyers. He will give you a copy of the powerpoint presentations if you ask.

The Convention was a real treat. I have attended the last 21 ATLA Annual Conventions and I have learned many valuable things at each one of them. ATLA has a new commitment to educating the public of the value of the civil justice system. It will be a long, expensive process but, I suggest, one worth the effort. We have to win back the hearts and minds of the jurors.

If you represent plaintiffs and are not a member of ATLA you should join. Not only will you get a great return on your money, but you will also help support the good fight.

The Wisconsin Supreme Court struck down the state’s med mal cap, saying that even under the rational basis test the cap did not meet constitutional muster. The med mal insurances companies and the docs are upset. What the insurance companies and the doctors don’t understand is that rational basis does not mean “any ole reason that some lobbyist and pr flack can speculate about” – at least not to real judges who take their job as guardians of the right to trial by jury seriously.

A New Jersey state court trial judge has certified a nationwide class action on behalf of unions and other third-party payors of health claims in a lawsuit alleging that the companies would not have paid for Vioxx had they been warned of the dangers of it. The suit is brought under the NJ Consumer Protection Act. Merck is headquartered in New Jersey.

The judge wrote that “there are significant factual and legal issues common to all class members to make adjudication through class action fair and efficient. Having each individual class member attempt to litigate their claims (separately) would result in needless duplicative discovery, undue expense to the parties as well as an undue burden on judicial economy.”

Although the merits of the litigation have not been decided, the right to bring the case as a class action is a major victory for the plaintiffs.

I wrote yesterday that a trial judge was going to permit the pathologist who performed the autopsy of the plaintiff’s decedent in the Vioxx case to testify.

How important is that testimony to the plaintiff? Well, a good guage of that is that Merck has appealed the decision in the middle of the trial. The court of appeals denied the request for review, and Merck appealed to the Texas Supreme Court.

How can Merck claim surprise when the doctor was on its witness list?

Lawyers have a lot to worry about. It’s an occupational hazard. Want one more stressor on your plate? If you’re filing electronically, and the court’s website runs so slowly that you start before the filing deadline but finish an hour after the deadline, your filing may not count. Read about it over at our Tennessee Business Litigation blog.

Well, I am still in Toronto at the ATLA Convention. The Covention has been great; it is wonderful to see old friends and meet new ones.

The word here is that the Vioxx trial in Texas is going great for the plaintiff. I have been receiving daily transcripts and from my review it seems like plaintiff’s lawyer Mark Lanier is scoring a lot of good points.

That being said, the first few trials in a products case usually result in defense verdicts. If this one does, people with “good” cases should not lose faith.

Here is a link to an interesting blog about probate litigation.

We were involved in a significant will contest several years ago that ended up going to the Tennessee Supreme Court (Rule 11 denied) and then, believe it or not, to the United States Supreme Court (cert. denied). It was interesting work and, quite frankly, alot of fun.

The blog looks good, too!

Over at our Tennessee Business Litigation blog, read about an Arkansas state judge’s decision to order sanctions against a nursing home chain in a class action suit. The sanctions arise from failure to produce emails and other electronic documents, and include $25,000 in attorney’s fees and possible jail time.

Contact Information